管理慢性冠状动脉综合征:我们如何实现最佳的患者结果?
Antonis A Manolis1, Theodora A Manolis2, Antonis S Manolis3
1Department of Medicine, Elpis General Hospital, Athens, Greece.
Expert review of cardiovascular therapy
|May 17, 2024
概括
慢性冠状动脉综合征 (CCS) 是死亡的主要原因. 本综述涵盖了CCS表型,诊断方法如CCTA和CAC评分,以及包括新疗法和心脏康复在内的多学科管理.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
背景情况:
- 慢性冠状动脉综合征 (CCS) 是全球主要的死亡原因和高住院率.
- 了解CCS表型对于有效的患者管理至关重要.
研究的目的:
- 审查CCS目前的诊断方式,包括非侵入性和侵入性测试.
- 讨论CCS的多学科管理策略和新兴的治疗选择.
- 突出心脏康复和耐火症状的先进治疗的作用.
主要方法:
- 对CCS及其管理的医学数据库进行文献搜索.
- 对诊断技术的审查:压力心声图,冠状动脉计算机断层扫描血管图 (CCTA),冠状动脉 (CAC) 评分,心声图和生物标志物.
- 对多学科管理方法的分析,包括风险因素修改,药物治疗和再血管化.
- 评估较新的治疗方法 (科尔奇辛,伊瓦布拉丁,拉诺拉,黑激素),心脏康复,植入式除器 (ICD) 和体外冲击波复血管.
主要成果:
- 压力回声心脏学定义了CCS表型.
- CAC评分和CCTA是评估动脉样硬化负担和功能意义的关键.
- 多学科的CCS管理包括风险因素控制,抗炎/抗胰岛症/抗血栓治疗和再血管.
- 新兴疗法和心脏康复改善了结果和生活质量.
结论:
- 有效的CCS管理需要一个多学科的方法,整合先进的诊断和量身定制的治疗.
- 新的药理学药物和生活方式干预措施,如心脏康复,对于改善患者的预后和生活质量至关重要.
- 先进的治疗方法为耐火性CCS症状和心脏突然死亡的预防提供了选择.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:29Chronic Pancreatitis II: Collaborative Care
85
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
85
01:26COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
493
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
493
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K